Health ❯Medicine

Pharmaceuticals

Pharmaceuticals Pharmaceuticals Clinical Trials Drug Development Drug Safety Investments Public Health Patient Care Stock Market Drug Development

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Experts link dry mouth, acid reflux, and vomiting caused by GLP-1 drugs like Ozempic to tooth decay and gum disease, urging preventive dental care.

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

University of Sydney Achieves First Real-Time Quantum Simulation of Molecular Light Reactions

‘Ozempic Mouth’ Identified as New Cosmetic Concern for Weight-Loss Drug Users

New Study Reveals Abortion Pill Complication Rate 22 Times Higher Than FDA Estimate

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

IUCN Red List Identifies 411 Fungi Species at Risk of Extinction

FDA Approves First New Oral Antibiotic for UTIs in Nearly 30 Years

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

Amy Schumer Embraces Mounjaro and Hormone Therapy for Improved Health

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Study Links Acetaminophen Use in Pregnancy to Increased ADHD Risk in Children

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock